What androgenic hair loss means

Clinicians more often use the term androgenetic because both androgen response and genetic susceptibility contribute. Affected follicles progressively produce finer shafts. Patterns differ: some people develop temple and crown loss, while others notice widening through the central part with preservation of the frontal edge.

The condition commonly presents as slowly declining density in a characteristic distribution. Short, fine hairs may remain among thicker ones, reflecting miniaturisation rather than follicles disappearing at once. The degree of visible loss does not reveal a person's hormone level, and androgenetic alopecia can occur even when routine hormone results are unremarkable.

Hair loss itself does not identify the diagnosis. Alopecia areata can present with defined patches, telogen effluvium with diffuse shedding, traction alopecia where repeated pulling occurs, and scalp ringworm with scale or broken hairs. More than one process can be present, which is why onset, distribution, scalp findings, and hair-care practices all matter.

Take baseline photographs in steady lighting and note whether the main change is shedding, recession, part widening, or patch formation. Before the appointment, list medicines, supplements, recent illness, dietary restriction, hormonal symptoms, pregnancy-related changes where relevant, and styling practices that create tension.

Treatment is tailored to the diagnosis and the person's priorities. It may involve a growth-supporting medicine, an anti-androgen approach suitable for the individual, cosmetic coverage, or hair restoration. A clinician should review medical and reproductive considerations before prescription treatment. Agree on how long-term maintenance, side effects, and photographic progress will be handled.

Request prompt examination for a sudden shed, rapidly expanding loss, smooth bald patches, loss of brows or lashes, or scalp pain, redness, thick scale, crusting, pus, or scarring. Those findings can signal another cause whose management differs from patterned miniaturisation.

New hair loss alongside marked fatigue, unexplained weight change, menstrual disruption, or other systemic symptoms also warrants medical review. After starting a product, obtain urgent help for breathing difficulty, facial swelling, faintness, or a severe widespread skin reaction; report less urgent but troubling effects to the prescriber.

Ask what supports androgenetic alopecia rather than another cause, whether any targeted investigation is justified, and which treatment fits your health history. Clarify whether the priority is slowing loss or gaining density, which areas retain miniaturised hairs, how response will be judged, and what symptoms should lead you to pause treatment and make contact.